Insights On Enterprise Solutions

  1. Enabling Commercial-Scale Biologics Manufacturing With Media Services 10/28/2026

    Consistent cell culture media across development underpins reliability at scale. Integrated manufacturing addresses supply, quality, and shelf-life uncertainty that can ripple into commitments.

  2. Unlocking Hidden Efficiencies In Cell And Gene Therapy Manufacturing 10/28/2026

    Identify hidden bottlenecks, cut batch variability, reduce costs, and protect quality. Learn strategies to streamline GMP transitions and speed commercialization.

  3. Connecting Oligonucleotide R&D With Early Clinical Scale Manufacturing 10/27/2026

    Watch the webinar for practical considerations that can support a smoother transition from oligonucleotide R&D to early clinical-scale manufacturing.

  4. Biomanufacturing Readiness: A Validation Model For Multiproduct Facilities 10/26/2026

    Optimize your validation strategy to meet evolving regulatory demands and product complexities with a scalable, efficient framework that accelerates facility readiness and ensures consistent quality.

  5. Bioconjugation Scale-Up: Data-Driven Strategies From 10 L To 500 L 10/23/2026

    Data-driven scale-up of ADC bioconjugation depends on matching mixing and temperature conditions. Solvent compatibility of single-use components and production-scale economics round out the decisions.

  6. Beyond Borders: What The Global Cell Therapy Community Can Learn From China's Rise 10/23/2026

    Political pressure favors regional insulation, but China's integrated approach to cell therapy development invites a different question: what does everyone else gain by studying it?

  7. From Laboratory To Launchpad: Japan's Cell And Gene Therapy Ecosystem Hits Its Stride 10/21/2026

    Japan is emerging as a credible cell and gene therapy hub as regulation, manufacturing, and capital advance, despite gaps in funding, talent, risk culture, and language.

  8. Advancing Drug Product Manufacturing With A Risk-Based Approach 10/20/2026

    Single-use systems are now standard, yet expectations for their use keep shifting. Integrity assurance across the lifecycle underpins a contamination control strategy that can withstand review.

  9. Linking Biomarkers To Clinical Proof-Of-Mechanism 10/19/2026

    Proving CNS delivery and target engagement in neurodegenerative therapies requires aligned clinical pharmacology and bioanalysis, from model selection to validated assays.

  10. Science-Driven Risk Mitigation In Single-Use Drug Product Processing 10/16/2026

    Explore how extractables and leachables from single-use systems can affect peptide stability, as well as how science-led approaches to component selection can reduce risk throughout manufacturing.